|
2025-06-06 |
2025-06-05 |
V
Vente
|
KNOBELMAN DEBORAH
President & Interim CEO
Dirigeant
|
24 838
-15.1%
0,87
21 554 USD
|
24 838
-15.1%
|
0,87
|
21 554 USD
|
|
|
2024-07-01 |
2024-06-28 |
A
Achat
|
BISCHOFBERGER NORBERT W
PRESIDENT & CEO
Administrateur exécutif
|
204 670
+1.9%
1,25
254 957 USD
|
204 670
+1.9%
|
1,25
|
254 957 USD
|
|
|
2024-07-01 |
2024-06-27 |
A
Achat
|
BISCHOFBERGER NORBERT W
PRESIDENT & CEO
Administrateur exécutif
|
410 848
+4.0%
1,17
478 843 USD
|
410 848
+4.0%
|
1,17
|
478 843 USD
|
|
|
2024-06-12 |
2024-06-12 |
A
Achat
|
BISCHOFBERGER NORBERT W
PRESIDENT & CEO
Administrateur exécutif
|
881 913
+13.6%
1,24
1 096 041 USD
|
881 913
+13.6%
|
1,24
|
1 096 041 USD
|
|
|
2024-06-12 |
2024-06-11 |
A
Achat
|
BISCHOFBERGER NORBERT W
PRESIDENT & CEO
Administrateur exécutif
|
744 308
+12.9%
1,09
814 571 USD
|
744 308
+12.9%
|
1,09
|
814 571 USD
|
|
|
2024-06-12 |
2024-06-10 |
A
Achat
|
BISCHOFBERGER NORBERT W
PRESIDENT & CEO
Administrateur exécutif
|
1 378 901
+31.6%
0,88
1 208 469 USD
|
1 378 901
+31.6%
|
0,88
|
1 208 469 USD
|
|
|
2024-02-23 |
2024-02-21 |
V
Vente
|
Olek Elizabeth A
SR VP, CLINICAL SCIENCE
Dirigeant
|
7 368
-3.7%
1,05
7 765 USD
|
7 368
-3.7%
|
1,05
|
7 765 USD
|
|
|
2024-02-23 |
2024-02-21 |
V
Vente
|
Frisbee Allison
SR VP, CORP OPERATIONS & LEGAL
Dirigeant
|
12 105
-5.6%
1,05
12 757 USD
|
12 105
-5.6%
|
1,05
|
12 757 USD
|
|
|
2024-02-23 |
2024-02-21 |
V
Vente
|
Lin Charles Y
SR VP, RESEARCH & DEVELOPMENT
Dirigeant
|
12 036
-4.9%
1,05
12 685 USD
|
12 036
-4.9%
|
1,05
|
12 685 USD
|
|
|
2024-01-05 |
2024-01-04 |
V
Vente
|
Dinsmore Christopher
Chief Scientific Officer
Dirigeant
|
7 366
-2.7%
1,18
8 718 USD
|
7 366
-2.7%
|
1,18
|
8 718 USD
|
|
|
2024-01-05 |
2024-01-04 |
V
Vente
|
DiMartino Jorge
Chief Medical Officer & VP
Dirigeant
|
12 009
-3.7%
1,18
14 214 USD
|
12 009
-3.7%
|
1,18
|
14 214 USD
|
|
|
2024-01-05 |
2024-01-04 |
V
Vente
|
Kosacz Barbara
COO & General Counsel
Dirigeant
|
10 676
-1.1%
1,18
12 636 USD
|
10 676
-1.1%
|
1,18
|
12 636 USD
|
|
|
2023-12-13 |
2023-12-12 |
V
Vente
|
Dinsmore Christopher
Chief Scientific Officer
Dirigeant
|
10 032
-3.6%
1,31
13 092 USD
|
10 032
-3.6%
|
1,31
|
13 092 USD
|
|
|
2023-12-13 |
2023-12-12 |
V
Vente
|
DiMartino Jorge
Chief Medical Officer & VP
Dirigeant
|
17 367
-5.0%
1,31
22 664 USD
|
17 367
-5.0%
|
1,31
|
22 664 USD
|
|
|
2023-11-17 |
2023-11-17 |
A
Achat
|
BISCHOFBERGER NORBERT W
President & CEO
Administrateur exécutif
|
97 935
+4.0%
1,08
106 162 USD
|
97 935
+4.0%
|
1,08
|
106 162 USD
|
|
|
2023-11-17 |
2023-11-16 |
A
Achat
|
BISCHOFBERGER NORBERT W
President & CEO
Administrateur exécutif
|
262 433
+12.0%
1,00
261 514 USD
|
262 433
+12.0%
|
1,00
|
261 514 USD
|
|
|
2023-11-17 |
2023-11-15 |
A
Achat
|
BISCHOFBERGER NORBERT W
President & CEO
Administrateur exécutif
|
1 370 688
+169.3%
0,80
1 102 718 USD
|
1 370 688
+169.3%
|
0,80
|
1 102 718 USD
|
|
|
2023-07-07 |
2023-07-06 |
V
Vente
|
Dinsmore Christopher
Chief Scientific Officer
Dirigeant
|
6 634
-2.3%
1,75
11 625 USD
|
6 634
-2.3%
|
1,75
|
11 625 USD
|
|
|
2023-07-07 |
2023-07-06 |
V
Vente
|
Al-Wakeel Yasir B.
Chief Financial Officer
Dirigeant
|
9 617
-2.7%
1,75
16 852 USD
|
9 617
-2.7%
|
1,75
|
16 852 USD
|
|
|
2023-07-07 |
2023-07-06 |
V
Vente
|
DiMartino Jorge
Chief Medical Officer & VP
Dirigeant
|
10 818
-3.0%
1,75
18 956 USD
|
10 818
-3.0%
|
1,75
|
18 956 USD
|
|
